P-161 A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment
| Autor: | Denis Smith, P. Chalbos, Fabienne Portales, S. Khier, Sylvain Poujol, Emmanuelle Samalin, S. Thezenas, Thibault Mazard, Antoine Italiano, Eric Assenat, M. Ychou, I. Solassol, Jean-Pierre Delord |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
0303 health sciences medicine.medical_specialty Second line treatment business.industry Hematology Gastrointestinal system medicine.disease Oxaliplatin Irinotecan 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Adenocarcinoma In patient business 030304 developmental biology medicine.drug |
| Zdroj: | Annals of Oncology. 26:iv47 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdv233.161 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|